Delivery Order SPE2DR25D2101-SPE2DR26F48VG
Award Date 3/2/26
Potential Completion Date 3/23/26
Potential Value $21K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $10,439.07 for TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. Place of performance is Conshohocken, PA 19428. The order is firm fixed price with an ultimate completion date of March 3, 2026. The delivery order was issued under the parent DLA Troop Support Medical indefinite delivery contract (SPE2DX), a global pharmaceutical support vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) under a firm fixed-price contract valued at $9,266.70. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Tavalisse 100 mg tablets (60-count) with a contract ceiling value of $20,878.16. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 19, 2026, and performance location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a contract ceiling value of $9,266.70. This firm fixed-price delivery order, which is not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- This delivery order, awarded June 18, 2025, to AmerisourceBergen Drug Corp represents a competitive, firm fixed-price procurement of Tavalisse 150 mg tablets (60-count packaging) valued at $18,563.67, with completion targeted for July 11, 2025. The award was issued by the Defense Logistics Agency (DLA) to support federal medical supply needs, with performance to be conducted at the contractor's Conshohocken, Pennsylvania facility. No set-aside designation was applied to this procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Tavalisse 100 mg tablets (60 count) with a ceiling value of $9,765.67. This is a firm fixed price delivery order with an ultimate completion date of January 13, 2026, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation....
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 60 tablets of Tavalisse 100 mg, a pharmaceutical product for immune thrombocytopenia treatment. The contract, which is a child order under a larger indefinite delivery vehicle, requires completion by November 19, 2025, and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a $9,296.97 delivery order to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count packages) on October 16, 2025, with an ultimate completion date of November 6, 2025. This firm fixed price, competitively awarded contract contains no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $20.7K delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 28, 2026, for the supply of Tavalisse 150 mg tablets (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by February 19, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...